Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Primal Pictures
15 May 2019
Primal Pictures provides a comprehensive foundation in anatomy and physiology of the whole body from gross to microanatomy. Information is presented in a structured, guided learning format supported by highly engaging materials to cover a wide variety of learning objectives and activities.
Topic Business strategies
Scrip
By Kevin Grogan 15 May 2019
Scrip editors will dissect Q1 sales and earnings reports of top pharma companies and focus on key trends, developments, and projected future impact.
Datamonitor Healthcare
By Louisa Joseph 13 May 2019
Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.
Topic Reimbursement
Citeline
By Doro Shin 13 May 2019
The fourth annual CARE Awards returned to Boston, Massachusetts 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Topic Clinical trials
Citeline, Scrip, Pharmaprojects
By Ian Lloyd 09 May 2019
April 17, 2019, Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019
Topic Drug approval Research
Meddevicetracker, Biomedtracker
03 May 2019
In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.
Medtech Insight, Meddevicetracker
03 May 2019
Pharma Intelligence offers a wealth of medtech industry news and strategic insight from key markets around the world, working in an interconnected global network of 65 journalists and over 300 in-house analysts to supply comprehensive analysis and reports.
Topic Medtech
Medtech Insight, Meddevicetracker
03 May 2019
Expert industry knowledge and support are the key pillars of having a stable understanding of the medtech market. The efficiency and convenience offered by Informa’s Ask the Analyst service provides just that to all our Medtech solution subscribers.
Topic Medtech
Citeline, Pharmaprojects
03 May 2019
Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.
Pink Sheet
By Derrick Gingery 03 May 2019
In his first speech to an outside group, Sharpless strikes a collaborative tone, saying he expects to listen to the advice of the FDA bar, as well as his own experts.
Topic FDA
HBW Insight
By Tom Gallen 03 May 2019
Bayer Consumer Health's sales declined at a single-digit rate in the first quarter of 2019, as the business continued to battle challenges in Europe and the US. Undeterred by this slow start to the year, the German firm says Consumer Health's performance will begin to turnaround in the coming months.
Topic Business strategies
Medtech Insight
By Ian Schofield 03 May 2019
Changes are being made to the UK’s Accelerated Access Collaborative to help streamline access to ground-breaking medicines and diagnostic tools in areas like dementia, diabetes and cancer.
Medtech Insight
By Elizabeth Orr 03 May 2019
Acting US FDA Commissioner Ned Sharpless described his vision for an efficient, adaptable agency on 2 May at the Food & Drug Law Institute’s annual conference in Washington, DC.
Scrip
By Joseph Haas 03 May 2019
ODYSSEY Outcomes data added to US label for Praluent; update includes claim for reduced cardiovascular incident risk and trial data indicating an all-cause mortality benefit.
Generics Bulletin
03 May 2019
The FDA has approved Samsung Bioepis’ Eticovo as the second biosimilar competitor to Amgen’s blockbuster rheumatoid arthritis biologic Enbrel. Amgen immediately sued for patent infringement.
Topic FDA Drug review
Pink Sheet
17 May 2019
Pink Sheet
17 May 2019
Scrip
17 May 2019
Pink Sheet
17 May 2019
Medtech Insight
17 May 2019
Pink Sheet
17 May 2019
Medtech Insight
17 May 2019
Scrip
17 May 2019
Scrip
17 May 2019
Medtech Insight
17 May 2019
Pink Sheet
17 May 2019
Pink Sheet
17 May 2019
Scrip
17 May 2019
Medtech Insight
17 May 2019
Pink Sheet
17 May 2019
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
22 May 2019 , 08:00 PST
Oregon , USA
Industry conference
28 May 2019 , 08:00 EST
Massachusetts , USA
Industry conference
03 Jun 2019 , 08:00 EST
Pennsylvania , USA
Conference
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date